8-K

CONFORMED COPY

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 24, 2008

CAMBREX CORPORATION

(Exact name of Registrant as specified in its charter)

DELAWARE	1-10638	22-2476135
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

ONE MEADOWLANDS PLAZA, EAST RUTHERFORD, NEW JERSEY	07073
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (201) 804-3000
 

Check the appropriate box if the Form 8K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2 below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(d) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

CAMBREX CORPORATION
Form 8-K
Current Report
March 24, 2008

Section 8 — Other Events

Item 8.01. Other Events

     Attached as Exhibit 99.1 is a copy of a press release of Cambrex Corporation dated March 21, 2008 announcing the recall of a customer’s product.

     Such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any registration statement or other document under the Securities Act of 1933.

Item 9.01 Exhibits

(c) Exhibits

(99.1) Press release issued by Cambrex Corporation dated March 21, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on behalf by the undersigned hereunto duly authorized.

		CAMBREX CORPORATION
Date:	March 24, 2008	By:	/s/ Gregory P. Sargen
		Name:	Gregory P. Sargen
		Title:	Vice President and CFO

Exhibit 99.1 Press release dated March 21, 2008.

EX-99.1

Exhibit 99.1

News Release

Date:	March 21, 2008
Contact:	Stephanie LaFiura
	IR Associate
Phone:	201-804-3037
Email:	stephanie.lafiura@cambrex.com
Release:	Immediate

CAMBREX CUSTOMER ANNOUNCED RECALL

     East Rutherford, NJ — March 21, 2008 — Cambrex Corporation (NYSE: CBM) announced today that one of its customers is recalling one of their products for which Cambrex currently supplies the active pharmaceutical ingredient (API).  Based on information provided to date, the recall decision is not linked in any way to Cambrex’s performance as the manufacturer of the API.  While this event may materially affect Cambrex’s 2008 performance, until the customer has resolved the issue, it is unknown what the impact will be.  The Company will monitor the situation and update its 2008 guidance, if necessary, when it has enough information to do so.

About Cambrex

     Cambrex provides products and services to accelerate the development and commercialization of small molecule active pharmaceutical ingredients (“APIs”), advanced intermediates and other products for branded and generic pharmaceuticals. The Company currently employs approximately 850 people worldwide. For more information, please visit http://www.cambrex.com.

# # #

Cambrex Corporation | One Meadowlands Plaza | East Rutherford, NJ 07073
Phone 201.804.3000 | Fax 201.804.9852 | www.cambrex.com